Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.
Sign Up For Latest News
This talk will cover key insights from the third AI100 report, AI Goes Mainstream: The Scaling Era and the Rise of Generative AI, set for release in November 2026. The report was commissioned by the AI100 standing committee and led by study panel chair Michael Wooldridge.

This talk will cover key insights from the third AI100 report, AI Goes Mainstream: The Scaling Era and the Rise of Generative AI, set for release in November 2026. The report was commissioned by the AI100 standing committee and led by study panel chair Michael Wooldridge.
Sessions run Wednesdays from 4:30–5:30 PM in CoDa E160. Each session features a different Stanford speaker; talk titles are announced by the organizers.

Sessions run Wednesdays from 4:30–5:30 PM in CoDa E160. Each session features a different Stanford speaker; talk titles are announced by the organizers.
This talk will explore the latest advances in computational protein design and structure prediction, highlighting NVIDIA technologies such as cuEquivariance and the Proteína family of models, including the latest RFdiffusion4 (RFD4)–Proteína developments. We will discuss how accelerated geometric deep learning and generative AI are enabling scalable, high-performance protein modeling and the design of novel proteins with tailored structures and functions.
Bio:
Youssef Nashed is a Senior Solutions Architect on NVIDIA's Healthcare and Life Sciences team. He joined NVIDIA from Bristol Myers Squibb (BMS), where he was a Senior Principal Scientist focused on machine learning and computational protein design. At BMS, Youssef led a team developing and deploying AI models for antibody discovery and development. He previously served as an Assistant Professor at Northwestern University and conducted research in structural biology at SLAC National Accelerator Laboratory at Stanford. Youssef began his career in high-performance and large-scale GPU computing at Argonne National Laboratory. His background spans computer science, mathematics, structural biology, and AI-driven protein engineering.
Location: CoDa W401

This talk will explore the latest advances in computational protein design and structure prediction, highlighting NVIDIA technologies such as cuEquivariance and the Proteína family of models, including the latest RFdiffusion4 (RFD4)–Proteína developments. We will discuss how accelerated geometric deep learning and generative AI are enabling scalable, high-performance protein modeling and the design of novel proteins with tailored structures and functions.
Bio:
Youssef Nashed is a Senior Solutions Architect on NVIDIA's Healthcare and Life Sciences team. He joined NVIDIA from Bristol Myers Squibb (BMS), where he was a Senior Principal Scientist focused on machine learning and computational protein design. At BMS, Youssef led a team developing and deploying AI models for antibody discovery and development. He previously served as an Assistant Professor at Northwestern University and conducted research in structural biology at SLAC National Accelerator Laboratory at Stanford. Youssef began his career in high-performance and large-scale GPU computing at Argonne National Laboratory. His background spans computer science, mathematics, structural biology, and AI-driven protein engineering.
Location: CoDa W401
Free and open to the public
Tuesday, November 8, 2022 [Link to join]
(ID: 996 2837 2037, Password: 386638)
Speaker: Luke Miratrix (Harvard University)
Title: A devil’s bargain? Repairing a Difference in Differences parallel trends assumption with an initial matching step
Discussant: Laura Hatfield (Harvard University)
Abstract: The Difference in Difference (DiD) estimator is a popular estimator built on the "parallel trends" assumption that the treatment group, absent treatment, would change "similarly" to the control group over time. To increase the plausibility of this assumption, a natural idea is to match treated and control units prior to a DiD analysis. In this paper, we characterize the bias of matching under a class of linear structural models with both observed and unobserved confounders that have time varying effects. Given this framework, we find that matching on baseline covariates generally reduces the bias associated with these covariates, when compared to the original DiD estimator. We further find that additionally matching on pre-treatment outcomes has both cost and benefit. First, matching on pre-treatment outcomes will partially balance unobserved confounders, which mitigates some bias. This reduction is proportional to the outcome's reliability, a measure of how coupled the outcomes are with the latent covariates. On the other hand, we find that matching on pre-treatment outcomes also undermines the second "difference" in a DiD estimate by forcing the treated and control group's pre-treatment outcomes to be equal. This injects bias into the final estimate, creating a bias-bias tradeoff. We extend our bias results to multivariate confounders with multiple pre-treatment periods and find similar results. We summarize our findings with heuristic guidelines on whether to match prior to a DiD analysis, along with a method for roughly estimating the reduction in bias. We illustrate our guidelines by reanalyzing a recent empirical study that used matching prior to a DiD analysis to explore the impact of principal turnover on student achievement.